miR-1290 Modulates the Radioresistance of Triple-Negative Breast Cancer by Targeting NLRP3-Mediated Pyroptosis

Investigators explored the roles and underlying mechanisms of miR-1290 in determining the sensitivity of TNBC to radiation therapy.